期刊文献+

睾酮衍生物ATES对6.5 Gy^(60)Co γ射线辐射C57小鼠外周血血象影响

The Effect of Testosterone Derivatives ATES on C57 Mice Model of 6. 5 Gy^(60)Co γ-ray Irradiation Peripheral Blood Cells
下载PDF
导出
摘要 研究旨在利用C57小鼠60Coγ射线辐照模型,观察睾酮衍生物ATES对小鼠照射后外周血血象的影响。48只C57小鼠经6.5 Gy60Coγ射线全身1次照射后建立骨髓型急性放射病动物模型。模型动物被随机分为照射对照组、单次给药组、照后连续n次给药组(n=2、3、4、5),每组8只。单次给药组于照射后2 h皮下注射ATES 10 mg/kg;连续给药组分别于照射后2 h和照后n d内每天一次皮下注射ATES 10 mg/kg;照射对照组于皮下注射同样体积的空白辅剂。观察照射前后小鼠外周血象变化与药物对体重的影响。与照射对照组相比较,ATES治疗能明显促进外周血白细胞数、中性粒细胞数、红细胞数、血红蛋白水平、血小板数以及单核细胞数的恢复。结论:ATES可以明显促进急性放射病小鼠的造血功能恢复,为研究临床治疗急性放射病提供实验依据。 A C57 mice model of 60Co γ–ray irradiation was observed Testosterone derivatives ATES on mice peripheral blood after irradiation effects. The bone marrow failure caused by severe acute radiation exposure model was established in 48 C57 mice which received total body irradiation by 6.5 Gy 60Co γ in single time irradiation. The irradiated mouse were randomly divided into 6 subgroups: controls (n=8) which received subcutaneous blank adjuvants, ATES single-dose group (n=8) which received subcutaneous injection of ATES (10 mg /kg) at 2h after irradiation, two-dose group (n=8)which received subcutaneous injection of ATES (10 mg /kg) at 2h ,day1 after irradiation, three-dose group (n=8) which received subcutaneous injection of ATES (10 mg /kg) at 2h ,day1 and 2 after irradiation, four-dose group (n=8) which received subcutaneous injection of ATES (10 mg /kg) at 2h, day1, 2 and 3 after irradiation, five-dose group (n=8) which received subcutaneous injection of ATES (10 mg /kg) at 2h ,day1, 2, 3 and 4 after irradiation respectively. Peripheral blood cells and weight were counted before and irradiation. Compared with control group, ATES administrated mouse’ white blood cell count, neutrophile granulocyte, red blood cell count, hemoglobin level, platelet, monocyte showed fasted recovery from high dose radiation. It is concluded that ATES treatment can significantly promote mice which suffered from bone marrow failure caused by severe acute radiation exposure bone marrow hematopoietic function recovery, to study clinical treatment of acute radiation sickness provide experiment evidence.
出处 《科学技术与工程》 北大核心 2014年第13期16-20,共5页 Science Technology and Engineering
基金 "重大新药创制"综合性新药研究开发技术大平台-药物分析及质量控制研究分题(2012ZX09301003-001-010) 国家自然科学基金项目(81072613)资助
关键词 睾酮 急性放射病 辐射损伤 C57小鼠 外周血血象 testosterone acute radiation sickness radiation injury C57 mice peripheral blood cells
  • 相关文献

参考文献7

二级参考文献31

  • 1罗庆良,NeelisKJ,WagemakerG.血小板生成素对猴急性放射病的治疗[J].中国实验血液学杂志,1996,4(3):324-328. 被引量:3
  • 2宋良文,孙丽,罗庆良,彭瑞云,黄海潇,高亚兵,马俊杰,张勇,尹纪业,王晓民,李小兵.两例极重度骨髓型放射病肺组织病变的病理学对比观察及分析[J].中华放射医学与防护杂志,2006,26(3):210-214. 被引量:1
  • 3艾辉胜,余长林,乔建辉,罗卫东,张石,郭梅,张锡刚,王丹红,孙琪云,牛文凯,李光,姚波,周振山,刘素刚,何耀忠,陈建魁,李晓兵,陈英,吴可,杨国山,刘英,胡凯勋.山东济宁^60Co辐射事故受照人员的临床救治[J].中华放射医学与防护杂志,2007,27(1):1-5. 被引量:20
  • 4吕秋军,丁林茂.治疗白细胞减少和粒细胞缺乏症药物[M].吕秋军.新药药理学研究方法.北京:化学工业出版社.2007:323-324.
  • 5Halpem W, Riccobene TA, Agostini H, et ol. Albugranin^TM, a recombinant granulocyte colony stimulating factor (G-CSF) ge- netically fused recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys [J]. Pharm Res, 2002,19(11 ): 1720-1729.
  • 6Dumont F, Roux A L, Bischoff P. Radiation countermeasure agents: an update. Expert Opin Ther Patents, 2010, 20:73-101.
  • 7Capizzi R L, Oster W. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol, 2000, 72: 425-435.
  • 8邢爽·细胞因子联合对极重度骨髓型ARS的实验治疗及作用机制研究.博士学位论文.北京:军事医学科学院,2009.
  • 9Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood, 1995, 86:419-431.
  • 10Kuter D J. New thrombopoietic growth factors. Clin Lymphoma Myeloma, 2009, 9:S347-S356.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部